GLP-1 drugs for weight loss represented an average of 11.4% of total annual claims for corporations in 2025, and 14.7% of total annual claims for multiemployers and public employers
We're always being the guinea pigs and that's what we love doing and we are available clinically
Why Theyre Usually Stacked Tissue healing is a multi-phase process
Desired Dose (mg) Supports 30+ peptides including GLP-1s (Tirzepatide, Retatrutide, Semaglutide), BPC-157, Semax, Selank, MOTS-c, Tesamorelin, NAD+, and peptide blends (BPC-157 + TB-500, GLOW, KLOW), with BAC water guidance to minimize injection site irritation
Other possible side effects include an allergic reaction, problems with gallbladder, kidneys, or pancreas, blurred vision, increased heart rate, and suicidal thoughts
Manufacturing and Supply of CRB-701, CRB-601, and CRB-913 We do not own or operate manufacturing facilities and rely on third-party contract manufacturing organizations or licensing partners to supply us with drugs for pre-clinical and clinical studies and commercial activities